Mayo Clinic: Polycystic Kidney, Autosomal Dominant trials
The registry lists 13 Polycystic Kidney, Autosomal Dominant studies with Mayo Clinic as lead sponsor. 4 are open to participants now and 2 have results posted.
Phase 2 3Phase 3 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Managing Depressive Symptoms in ADPKDRecruitingNCT07745920Not applicable
- NOX4 and Related Biomarkers in ADPKDRecruitingNCT04630613
- Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)RecruitingNCT04344769
- A Prospective Observational Study of Foam Sclerotherapy .RecruitingNCT04111692
- Pasireotide LAR in Severe Polycystic Liver DiseaseCompletedNCT01670110Phase 2Results posted
- Octreotide in Severe Polycystic Liver DiseaseCompletedNCT00426153Phase 2/3Results posted
- Role of ROS and cAMP-PKA Biomarkers in ADPKDActive, not recruitingNCT07217158
- Intrarenal Microvasculature in ADPKDActive, not recruitingNCT05288998
- A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKDActive, not recruitingNCT05193981
- Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium AdministrationCompletedNCT05190744Phase 2
- Assessment of Longitudinal Changes in Endothelial Function and Oxidative Stress in Normotensive Patients With ADPKDCompletedNCT03493802
- New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT02250287
- Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain StudyCompletedNCT00571909Not applicable